“FACTORS ASSOCIATED WITH MORTALITY IN CRITICALLY ILL COVID-19 PATIENTS INDICATED FOR OXIRIS HEMOADSORPTION”, YHCĐ, vol. 67, no. 9, Sept. 2026, doi: 10.52163/yhc.v67i9.6632.